Significance of prostate-specific antigen-doubling time on survival of patients with hormone refractory prostate cancer and bone metastasis : Analysis on 56 cases of cancer-specific death
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-02-01
著者
-
Shimazaki Jun
Department of Urology, School of Medicine, Chiba University
-
Murakami Shino
Department Of Urology Asahi General Hospital
-
SHIMBO Masaki
Department of Urology, Asahi General Hospital
-
NAKATSU Hiroomi
Department of Urology, Asahi General Hospital
-
Nakatsu Hiroomi
Department Of Urology Asahi General Hospital
-
TOMIOKA Susumu
Department of Urology, School of Medicine, Chiba University
-
AMIYA Yoshiyasu
Department of Urology, Asahi General Hospital
-
Amiya Yoshiyasu
Department Of Urology Asahi General Hospital
-
Shimazaki Jun
Department Of Urology Chiba University Graduate School Of Medicine
-
Shimazaki Jun
Department Of Ophthalmology Tokyo Dental College
-
Tomioka Susumu
Department Of Urology Asahi General Hospital
-
Murakami Shino
Department Of Urology
-
Shimbo Masaki
Department Of Urology Asahi General Hospital
-
Shimazaki Jun
Department Of Ophthalmology School Of Medicine Keio University
-
SHIMAZAKI JUN
Department of Dermatology, School of Medicine, Chiba University
関連論文
- Endocrine therapy for recurrence after definitive radiotherapy in patients with prostate cancer
- External beam radiation monotherapy for prostate cancer
- Three Distinct Commonly Deleted Regions of Chromosome Arm 16q in Human Primary and Metastatic Prostate Cancers
- Localization of a Tumor Suppressor Gene Associated With Progression of Human Prostate Cancer Within a 1.2 Mb Region of 8p22-p21.3
- Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10ng/mL
- Disposable Eyelid-Warming Device for the Treatment of Meibomian Gland Dysfunction
- Combined Medical and Surgical Treatment of Severe Vernal Keratoconjunctivitis
- Characteristics of Androgen-Independent Growth of Androgen-Responsive Shionogi Carcinoma 115 Cells
- Clinical Evaluation of Serum Prostate-Specific Antigen-Alpha^1-Antichymotrypsin Complex Values in Diagnosis of Prostate Cancer: A Cooperative Study
- PRLTS Gene Alterations in Human Prostate Cancer
- Microsatellite Instability and Other Molecular Abnormalities in Human Prostate Cancer
- Mutational Analysis of CDKN2 (CDK4I/MTS1) Gene in Tissues and Cell Lines of Human Prostate Cancer
- p53 Mutations Occur in Clinical, but Not Latent, Human Prostate Carcinoma
- Significance of prostate-specific antigen-doubling time on survival of patients with hormone refractory prostate cancer and bone metastasis : Analysis on 56 cases of cancer-specific death
- Usefulness of tonsil forceps in radical retropubic prostatectomy
- Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer
- Kidney stone disease and risk factors for coronary heart disease
- Significance of capsular atachment and invasion of cancer tissues prostate cancer
- Progression of prostate cancer to neuroendocrine cell tumor
- Change in the ratio of free-to-total prostate-specific antigen during progression of advanced prostate cancer
- Immunohistochemical finding of α-1-antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancer
- The Impact of HLA-A Matching in Corneal Transplantation
- Evaluation of functional bladder capacity in Japanese children
- Prostate-Specific Antigen Levels from a Mass Screening Program Using Highly Sensitive RIA Kits
- Surgical Approach to Tumor Thrombus of Renal Cell Carcinoma at the Level between Hepatic Vein and Diaphragm
- Endoscopic Treatment of Superficial Bladder Cancer with the Holmium : YAG (Ho : YAG) Laser
- Influence of Osteoarthritis on Serum Marker Levels of Bone Formation and Resorption in Patients with Benign Prostatic Hypertrophy
- Relationship between Prostate-Specific Antigen,Clinical Stage,and Degree of Bone Metastasis in Patients with Prostate Cancer:Comparison with Prostatic Acid Phosphatase and Alkaline Phosphatase
- DISEASE PROGRESSION IN STAGE A PROSTATE CANCER
- RADIATION THERAPY FOR PROSTATE CANCER CONFINED TO PELVIS
- DIURNAL RHYTHM OF SERUM γ-SEMINOPROTEIN IN PATIENTS WITH UNTREATED PROSTATE CANCER: COMPARISON OF THE ORIGINAL AND REVISED ASSAY KITS
- Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia : A prospective study
- Serum Interleukin-6 Levels after Urologic Operations
- Relationship between Grade of Varicocele and the Response to Varicocelectomy
- Induction of Programmed Death/Apoptosis in Androgen-dependent Mouse Mammary Tumor Cell Line (Shionogi Carcinoma 115) by Androgen Withdrawal
- Treatment of Urinary Stones on an Outpatient Basis by Extracorporeal Shock Wave Lithotripsy using a EDAP LT-01 (+)
- Management of Candida albicans Donor-to-Host Transmission Following Penetrating Keratoplasty
- Changes in Cytosolic Androgen Receptor after Administration of Testosterone of Androgen-Dependent Mouse Mammary Tumor (Shionogi Carcinoma) and Its Sublines of Altered Androgen Dependency
- Low Molecular Weight Component of Androgen Receptor in Cytosols from Benign Hypertrophic Human Prostate treated with High KCl Solution
- Properties and Androgen-Induced Changes of Arginase in Kidney and Ventral Prostate of Rats
- Effects of Testosterone Administration on RNA Synthesis in Kidney of Castrated Rats
- Effect of Sex Hormones on RNA Synthesis of Androgen-Dependent Mouse Mammary Tumor (Shionogi Carcinoma)
- Effects of Inhibitors of Nucleic Acids and Protein Biosynthesis on the Rate of 5α-reduction of Testosterone, the Activity of DNA Polymerase and Nucleic Acid Contents of Testosterone-stimulated Prostate of Rats
- Incorporation of Testosterone and 5α-Dihydrotestosterone into Rat Ventral Prostate in vitro
- Solubilization of Testosterone 5α-Reductase from Nuclear Fraction of Rat Ventral Prostate
- Further Studies on Testosterone 5α-Reduction in Rat Ventral Prostate
- Inhibition of Nuclear Testosterone 5α-Reductase in Rat Ventral Prostate by Estrogens and Anti-Androgens
- Properties of Testosterone 5α-Reductase of Purified Nuclear Fraction from Ventral Prostate of Rats
- Surgical Management of Severe Canaliculitis Due to Intracanalicular Plug Migration Using Fish-Hook-Type Retractors : A Report of Two Patients
- Binding to R 1881 (Methyltrienolone) of Proteins from Human Benign Prostatic Hypertrophy
- Free Amino Acids in the Caput and the Cauda Epididymis of Adult Rats
- Effect of Testosterone Administration on the Free Amino Acids and Conversion of Arginine to Proline and Glutamate in the Rat Ventral Prostate
- 3α-Reduction of 5α-Dihydrotestosterone by Rat Ventral Prostate
- Effects of Estrogen Administration on Testosterone-Induced Growth and Increase in Enzyme Activities in the Ventral Prostate of Castrated Rats
- Reduction of 5α-Position of Testosterone in the Rat Ventral Prostate
- Studies on the Relation between Dermatoses and Bacterial Allergy, with Special Reference to Micrococcus Pyogenes and Streptococcus Hemolyticus
- Binding of Chlormadinone Acetate to Cytosol from Human Benign Prostatic Hypertrophy
- Effect of Hypolipidemia on Testosterone-Stimulated Prostatic Growth in Castrated Rats
- Effect of Estrogen Administration on Activities of Testosterone 5α-Reductase, Alkaline Phosphatase and Arginase in the Ventral and the Dorsolateral Prostates of Rats
- Inhibition by Various Steroids on Dihydrotestosterone Binding to Androphilic Protein in Human Benign Prostatic Hypertrophy
- Androphilic Proteins in Cytosols of Human Benign Prostatic Hypertrophy
- Properties of Androphilic Proteins in Cytosols of Human Benign Prostatie Hypertrophy
- Editorial Comment to Association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy
- Dihydrotestosterone-binding protein in cytosols of normal and hypertrophic human prostates, and influence of estrogens and anti-androgens on the binding.
- Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
- Progestin-binding protein in human benign prostatic hypertrophy.